HEATR5A

Across TCGA pan-cancer cohorts, HEATR5A mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated HEATR5A data layer compared with 23 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher HEATR5A mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated HEATR5A expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

LUAD, PDAC, and GBM are the cancer types where HEATR5A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.452	0.883	.013	13	view →
PDAC	OS	Tertile	II,III,IV	0.552	0.287	.021	3	view →
GBM	DFS	Tertile	All	0.235	0.451	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

HEATR5A–LUAD (DFS)

Open the LUAD breakdown →